The Australasian Association of Clinical Biochemists and the Australian Institute of Medical Scientists Conference Organising Committee invites delegates to submit abstracts for the AACB AIMS Combined Scientific Meeting. 

KEY DATES:

Call for Abstracts                           CLOSED
Notifications of Acceptance           ADVISED
Earlybird Registration * extended*    CLOSED
Presenter Registration Deadline    NOW DUE



ABSTRACT SUBMISSION

Abstracts must be submitted online.

They must be submitted as a Microsoft word document.  A sample abstract has been provided to assist you in following the required format.

When saving your Microsoft word document, please save the document using your surname e.g. ‘smith.doc’.  If you are submitting more than one abstract please label as ‘smith1.doc, smith2.doc etc’.

When completing the online submission form, you will be asked to choose an AACB Abstract category or an AIMS Abstract category.  Please complete all details in the online form.  If you wish to submit more than one abstract, you can do this by logging-in using the ‘access key’ which will be provided when you have opened your 'abstract account' (this will be sent to you via email). You can then log-in to your submission file and add another abstract submission.  

Submissions are being called for ORAL or POSTER presentations
Click here to view further details on the Oral presentations, Poster presentations (including ** NEW ** 'Poster Hot Topic' sessions). Details on the Oral and Poster Prizes are also available. 

AACB categories for submissions include:
Molecular/Genetics 
General Biochemistry 
Automation 
Endocrinology 
Lab Management  
Workforce Development

AIMS categories for submissions include:
Haematology 
Cytology
Quality Assurance
Immunohaematology
Coagulation
Microbiology
Immunology
Histopathology
Biochemistry
Genetics
Education and Management
Molecular Pathology

All abstracts will be selected according to the following criteria:
 ► Originality and interest 
 ► Structure and clarity 
 ► Scientific validity 
 ► Potential significance
  

GENERAL INFORMATION

1. Abstracts must be in English.  
2. Abstracts must be typed in the required format – please refer to the Sample Abstract.  
3. Word Limit: maximum 300 words including title and authors names. Abstracts over this limit will not be accepted.  
4. If you wish to include QAP data in your abstract you must obtain  prior written consent from RCPA Quality Assurance Programs. Please send your request to Ms Janice Gill at Jan.Gill@rcpaqap.com.au.
5. Abstracts will be reproduced as submitted by the author with minimal editing.  
6. Abstracts should be thoroughly checked for correct spelling and grammar before submitting. 
7. Please ensure that you include all information requested on the online abstract submission form. 
8. Abstracts will be reviewed by the Scientific Organising Committees to evaluate clarity, content and relevance to clinical chemistry, medical laboratory science and medical science. Invited Speakers' Abstracts will not be reviewed.  
9. The Scientific Organising Committee reserves the right to reject unsuitable topics. 

Please note all accepted presenters must register to attend the conference. If you have not registered and paid by 13 August 2010 your paper may be taken out of the program. 

FORMAT & CONTENT

Word Limit	300 words Abstracts over 300 words will not be accepted. If your abstract is over 300 words this will be sent back to you to reduce to the 300 word limit.
Font Type	Times New Roman
Font Size	12 point
Line Spacing	Single
Title	Uppercase and Bold (leave one line space between authors & title)
Presenting Author Co-Authors	Given name then Surname.  Presenting author is bold and underlined.   Initials then Surname.  If more than one author & address insert a superscript number at the end of the surname after a comma (for each author).   Left justify
Author(s) Address (next line under authors)	Include Dept, institution, city, state and country.    If more than one author / address designate each author’s address by a superscripted  number before the address.   Left justify
Email address	Insert presenting authors email address  Left justify  (leave one line space between email address & main body)
Main body	The abstract should be an informative document able to stand alone in its content and meaning. The main body, wherever possible, should be presented under the following headings: Introduction: the study objectives.   Methods: a brief statement of methods used.   Results: a summary of results, including statistical significance in text; do not include   tables or figures. It is not sufficient to say that results will be discussed.  Conclusion: a brief but clear conclusion drawn from the results shown. Do NOT include, sub-headings, diagrams, tables, figures or references, biographical information, printing enhancements or formatting such as underlining, bold text, boxes etc.  The content must not have been previously published.  Use abbreviations with restraint. Terms must be spelt fully the first time they appear. Fully justify ** If you wish to include QAP data in your abstract you must obtain  prior written consent from RCPA Quality Assurance Programs. Please send your request to Ms Janice Gill at Jan.Gill@rcpaqap.com.au **

ABSTRACT ACKNOWLEDGEMENT 

1. An email acknowledging your abstract account and submission will be sent to you automatically when you first save your presenting author details.  
2. When you have completed the abstract submission process and uploaded your abstract, you will be able to view and edit your abstract submission details by CLICKING HERE and entering your access key provided in the confirmation email. 
3. All correspondence will be sent to the e-mail address from which the submitted abstract was received. 
4. If you wish to make changes to your abstract please DO NOT resubmit your abstract.  Send your revised abstract, quoting your reference ID provided in your confirmation email, to aacbaims2010@arinex.com.au.

All presenters will be required to register for the Conference and pay the registration fee; the Early Bird registration deadline is 13 August 2010. 
 

AUTHORISATION & PUBLICATION OF ABSTRACTS

By submitting this abstract you are consenting to the publication of your abstract, if accepted, in the Conference Handbook. If accepted for an AACB Abstract or AIMS abstract, you are consenting to the publication of your abstract in the respective journals as noted below.

Successful AIMS abstracts will be published in the Australian Journal of Medical Science.

Successful AACB abstracts may also be published in the supplement of The Clinical Biochemist Reviews, subject to CBR editorial team acceptance.  

AACB SUBMISSION ONLY

All submissions for the AACB categories must complete the below AACB Copyright and Declaration of Interest form, as part of the submission process.

AACB Copyright
The author/s assigns copyright to the Australasian Association of Clinical Biochemists Inc., (AACB). Statements contained therein are the responsibility of the author(s). The corresponding author should sign the Copyright Assignment form on behalf of all the authors of the abstract and return it at the time of abstract submission. The AACB reserves the copyright and renewal of all published material, as agreed in the assignment of copyright, and such material may not be reproduced in any form without the written permission of the AACB.

AACB Declaration of Interest
Definition: A conflict of interest exists where there is a divergence between the individual interests of a person and their professional obligation to the AACB such that an independent observer might reasonably question whether the professional actions or decisions of that person are influenced by their own interests. 

Policy of the AACB on Conflict of Interest at Scientific Conferences and Educational Activities: 

Presentations made at annual scientific conferences or other educational activities and articles published in publications under the control of the AACB shall also be covered by the general principles of conflict of interest such that all authors or presenters must disclose, on the Declaration of Interest form, any affiliation with or financial involvement in, or payments or other assistance in kind from, any organisation with direct interest in the subject matter. The reason for requesting disclosure of possible conflict of interest is not to censure or exclude speakers, but to inform the audience or reader so they may decide for themselves whether or not a presentation is biased. Information from the disclosure will be disclosed to participants but will not be used to exclude speakers or authors from an activity.